Shanghai Yuandong Biopharmaceutical

Shanghai Yuandong Biopharmaceutical is a China-based biopharmaceutical company specializing in the development, manufacturing, and commercialization of recombinant protein therapeutics and other biological products. The company is well-known for its production of interferon-based treatments and granulocyte colony-stimulating factor (G-CSF) products used in the treatment of viral infections and oncology-related side effects. Operating primarily within the domestic Chinese market, it maintains GMP-certified manufacturing facilities in Shanghai to support its portfolio of approved biologics. Shanghai Yuandong Biopharmaceutical focuses on addressing unmet medical needs in infectious diseases and supportive cancer care through its established R&D and production capabilities.